Professional Documents
Culture Documents
Antigen Processing & Presentation PDF
Antigen Processing & Presentation PDF
PROCESSING &
PRESENTATION
Professor David Wraith
d.wraith@bham.ac.uk
Learning Objectives
■ The immune system has evolved to ■ CD8+ T cells protect against viruses
combat infection and cancer
■ This has generated two arms of ■ The class I pathway handles intra-
cellular immunity and two paths of cytoplasmic antigens
antigen processing
■ This lecture will reveal where
■ Class II molecules present antigen to cytoplasmic antigens are fragmented,
CD4+ T cells and generally handle how they bind class I molecules and
exogenous antigens what controls class I MHC-peptide
association and assembly
■ This lecture will explain class II
molecule assembly, traffic and ■ Reading: Janeway’s Immunobiology
antigen binding 9th Edition, Chapter 6
How Are T cells
Alerted To The
Infection?
Figure 5-2
Two Primary Antigen Processing Pathways
MHC Class I MHC Class II MHC Class I MHC Class II
MHC polymorphism
■ Proteins from individual MHC alleles can
differ from one another by up to 20 amino HLA locus Possible alleles*
acids, making each variant protein quite
distinct
HLA-A 2,884
■ Differences are localized to exposed
HLA-B 3,589
surfaces of the outer domain of the HLA-C 2,375
molecule and to the peptide-binding
groove in particular HLA-DP 16,036
■ The polymorphic residues that line the HLA-DQ 34,528
peptide-binding groove determine the HLA-DR 11,431
peptide-binding properties of
different MHC molecules *IMGT-HLA
database
Two Primary Antigen Processing Pathways
Secretory
Vesicle Golgi
Apparatus Endoplasmic
Reticulum
Endogenous
Viral & Tumour
Antigens
CLASS I & CD8
T cells
Exogenous
Antigens Nucleus
CLASS II & CD4 Endosome
T cells Lysosome
Biosynthetic Pathway of MHC Glycoproteins
• Calnexin is a CHAPERONE
protein
Secretory
Vesicle Golgi
Apparatus Endoplasmic
Reticulum
Endogenous
Viral & Tumour
Antigens
CLASS I & CD8
Exogenous
Antigens Nucleus
CLASS II & CD4 Endosome
Lysosome
Defective Ribosomal Products
Schild &
Ramensee:
Nature (2000)
404:709-710
Proteasome from Archaebacterium
Immunoproteasome
LMP2 MECL1
b1i b2i
b1 b2
IFN-g
b7
b3
b6
b4
b5
LMP7
b5i
Constitutive Proteasome Immuno
3 proteolytic subunits b1, Proteasome
b2 & b5
Proteasome Function
• Nascent Class I inserted into ER via signal recognition pore (SRP) and stabilised by interaction
with chaperone GRP78 (BiP)
• Asn86 of human class I is glycosylated. Sugar chain interacts with chaperone Calnexin
• Association with b-2m leads to calreticulin (CRT) binding
• Oxidoreductase (ERp57) and tapasin form stable unit via S-S bind and will only release class I
from TAP, for traffic to the cell surface, when a peptide of sufficient affinity has bound
But………………..
■ How are CD8 cells primed against viruses that do not infect dendritic cells?
■ There is an alternative pathway of presentation that allows exogenous antigens to
enter the class I pathway
■ This is known as ‘cross-presentation’
■ Cross-presentation is controlled by TLR signals that optimise presentation of
antigens from infectious agents
Cytotoxic T Cell Recognition
T CELL PRIMING TARGET CELL LYSIS
■ The endogenous route of ■ Most nucleated cells express class I MHC
antigen presentation is most and can present antigen by the
effective for those antigens endogenous route
expressed within dendritic
cells ■ The exogenous route of antigen
presentation is inefficient for cytotoxic T
■ The exogenous route of cell killing of target cells
antigen presentation can
result in CD8 cell activation by
DC